{"nctId":"NCT04048356","briefTitle":"Chlorhexidine vs. Iodine for Vaginal Preparation in Urogynecologic Procedures","startDateStruct":{"date":"2019-07-15","type":"ACTUAL"},"conditions":["Pelvic Organ Prolapse","Urinary Incontinence","Pelvic Floor Disorders","Gynecologic Disease","Post-Op Infection","Surgical Site Infection","Urinary Tract Infections"],"count":137,"armGroups":[{"label":"Chlorhexidine gluconate","type":"EXPERIMENTAL","interventionNames":["Drug: Vaginal scrub, to be applied vaginally and perineally immediately prior to surgery."]},{"label":"Povidone Iodine","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Vaginal scrub, to be applied vaginally and perineally immediately prior to surgery."]}],"interventions":[{"name":"Vaginal scrub, to be applied vaginally and perineally immediately prior to surgery.","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Female Subjects \\>18 years of age\n* English or Spanish speaking/reading\n* Must be able to provide informed consent\n* Undergoing urogynecologic procedures or surgery\n\nExclusion Criteria:\n\n* Pregnant - all patients are verified regarding pregnancy status prior to gynecologic surgical intervention at all sites of surgery - for patients who are premenopausal and have a uterus, a urine pregnancy test is administered in the preoperative setting. Pregnancy status is also determined prior to this in the office setting by interview and patient provided history prior to offering surgery to the patient.\n* Inability to return for follow-up visits\n* No concurrent need for vaginal antisepsis, such as cases of sacral neuromodulation\n* Lack of telephone\n* Known allergy to either antiseptic agent\n* Prisoners will not be eligible to participate in this study","healthyVolunteers":true,"sex":"FEMALE","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Rate of Urinary Tract Infection","description":"Urinary tract infection as defined by positive urine culture of \\>10,000 cfu, or empirically treated symptoms.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]}]},{"type":"SECONDARY","title":"Rate of Surgical Site Infection","description":"Surgical site infection as defined by CDC guidelines: https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Vaginal Irritation","description":"Vaginal irritation (including specific symptoms of discomfort, burning, or itching) based on a 5-point scale (Likert type, from 0 minimum/better to 5 maximum/worse, total score reported))","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"50","spread":null},{"groupId":"OG001","value":"50","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"2","spread":null}]},{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":61},"commonTop":[]}}}